Showing results (241-250 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|December 9, 2025
Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicineCharles Dodds, Rachelle Dawson, Alexander Lim, et al.Therapeutic Advances in Psychopharmacology|November 18, 2024
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI studyHai-Yang Wang, Bei-Yan Guan, Shi-Yao Wang, et al.Therapeutic Advances in Psychopharmacology|August 2, 2024
Long-acting antipsychotic treatments: focus on women with schizophreniaSofia Brissos, Vicent Balanzá-MartínezTherapeutic Advances in Psychopharmacology|July 29, 2024
Sublingual asenapine for agitation in malabsorptive states: three patient casesBradley G Burk, Kyle Humphreys, Jim Waites, et al.Therapeutic Advances in Psychopharmacology|November 2, 2023
Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysisNa Zhou, Chengchuan Chen, Yubei Liu, et al.Therapeutic Advances in Psychopharmacology|September 13, 2023
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?Robin EmsleyTherapeutic Advances in Psychopharmacology|November 29, 2023
A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adultsShen He, Yimin Yu, Jingjing Huang, et al.Therapeutic Advances in Psychopharmacology|February 19, 2024
Patients' awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychoticsJasmina Mallet, Clément Dondé, Caroline Dubertret, et al.Therapeutic Advances in Psychopharmacology|May 15, 2024
Clozapine-induced cholinergic urticaria: a case reportNadia El Ouni Amami, Husen Ali-Diabacte, Sarra Ateb, et al.Therapeutic Advances in Psychopharmacology|September 29, 2023
Ketamine for bipolar depression: an updated systematic reviewFarhan Fancy, Sipan Haikazian, Danica E Johnson, et al.Pageof 55